In patients with RA, this “alternative” mechanism is mainly triggered by the binding of B-cell-activating factor (BAFF) to the BAFF receptor (BAFF-R), which is associated with an overabundance of autoantibody-producing B cells [30]. Here, TNFSF13B is linked to rheumatoid arthritis.